COVID-19 vaccination drive | Second nation-wide dry run to take place on January 8

Around 1.7 lakh vaccinators and 3 lakh vaccination team members have been trained in vaccine administration, said the health ministry.

Moneycontrol News
January 06, 2021 / 08:29 PM IST

India has approved two COVID-19 vaccines for emergency use.

Ahead of the vaccine roll-out, a second dry run is set to take place across all districts in India on January 8, with an aim to ensure efficient planning and management for vaccine delivery across the country.

"As a simulation of actual execution, another round of dry run/mock drill in all 700+ districts of all States/UTs (except Uttar Pradesh and Haryana which have already conducted the dry run in all districts on January 5 and 7, respectively) is planned on January 8, 2021 to ensure efficient planning and management for vaccine delivery in each district of all States/UTs," the government said in a statement on January 6.

This dry run will help the state, district, block and hospital-level officers get familiar with all aspects of a COVID-19 vaccine rollout, the statement said.

"The dry run will help administrators in strengthening the linkages between planning, implementation, and reporting mechanisms, identification of any residual challenges prior to the actual implementation and to provide confidence to the programme managers at all levels to carry out a smooth implementation of the vaccination drive," it said.

Union Minister of Health and Family Welfare Dr Harsh Vardhan will hold a meeting with the state/UT health ministers January 7, 2021, in this regard.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Two COVID vaccines have been given emergency use authorisation by the Drugs Controller General of India (DCGI), and the roll out of COVID-19 vaccine is expected to begin by January 13.

How will it work? 

Each district will identify three types of session sites, similar to the previous dry run including a public health facility (District Hospital/Medical College), private health facility, and rural or urban outreach sites.

The entire planning of the vaccination drive including beneficiary registration, microplanning, and vaccination at the planned session site, will be tested under the leadership of District Collector or District Magistrate.

The health ministry will be in constant touch with the states/UTs throughout the day to seek feedback and provide support and, ensure timely resolution of the identified challenges before the actual vaccination roll-out.

To facilitate the entire vaccination process, a software,‘Co-WIN’, has been developed by the health ministry for real time information of vaccine stocks, their storage temperature, and individualized tracking of beneficiaries for COVID-19 vaccine.

This software will assist the programme managers across all levels in conducting the vaccination sessions.

A dedicated 24x7 call centre has also been established for technical queries of Co-WIN users.

The cold chain infrastructure (like walk-in-freezers, walk-in-coolers, ice-lined refrigerators, deep freezers) along with sufficient supplies of syringes and other logistics have been ensured to begin COVID-19 vaccination drive.

"Around 1.7 lakh vaccinators and 3 lakh vaccination team members have been trained on the process to be followed at the vaccination sites which include beneficiary verification, vaccination, cold chain and logistics management, bio-medical waste management, AEFI management and reporting on Co-WIN software," the government said.

 
Moneycontrol News
TAGS: #coronavirus #Covid-19 #COVID-19 vaccine #COVID-19 vaccine tracker #Current Affairs #India
first published: Jan 6, 2021 06:53 pm